NCT07453459 Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
| NCT ID | NCT07453459 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Cervical Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-04-17 |
| Primary Completion | 2027-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-04-17 with a primary completion date of 2027-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is testing and implementing an equity-focused, community-based intervention that improves women's access to cervical cancer screening and adherence to follow up after an abnormal result. The study's objective is to assess and compare the feasibility of different methods of distributing at-home HPV testing kits for cervical cancer screening among individuals who are under-screened.
Eligibility Criteria
Inclusion Criteria: * Are age 25-65 * Has an intact cervix * Self-reports that they have not been screened for cervical cancer within the last 3 years * Has a smartphone * Has access to the internet to engage with the Teal Health mobile app and complete a Zoom interview * Can read, speak, write and understand English well enough to take a survey and complete an interview Exclusion Criteria: * Abnormal vaginal bleeding or discharge * A history of cancer of the reproductive system * A compromised immune system * Prior Diethylstilbestrol (DES) exposure * Currently pregnant or are within 6 weeks of giving birth * Treatment for a cervical precancer (e.g., loop electrosurgical excision procedure or conization) in the last 25 years.
Contact & Investigator
Michelle Silver, PhD, ScM
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT07453459 clinical trial?
This trial is open to female participants only, aged 25 Years or older, up to 65 Years, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07453459 currently recruiting?
Yes, NCT07453459 is actively recruiting participants. Contact the research team at michelle.silver@wustl.edu for enrollment information.
Where is the NCT07453459 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT07453459 clinical trial?
NCT07453459 is sponsored by Washington University School of Medicine. The principal investigator is Michelle Silver, PhD, ScM at Washington University School of Medicine. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.